16, 553 (2011). 16. A. Akki, M. Zhang, C. Murdoch, A. Brewer, A. M. Shah, J. Mol. Cell. Cardiol. 47, 15 (2009). 17. C. Jung, A. S. Martins, E. Niggli, N. Shirokova, Cardiovasc. Res. 77, 766 (2008). 18. C. E. Murdoch, M. Zhang, A. C. Cave, A. M. Shah, Cardiovasc. Res. 71, 208 (2006). 19. C. Hidalgo, G. Sánchez, G. Barrientos, P. Aracena-Parks, J. Biol. Chem. 281, 26473 (2006). 20. Y. Li, M. A. Trush, Biochem. Biophys. Res. Commun. 253, 295 (1998). 21. J. A. Byrne et al., Circ. Res. 93, 802 (2003). 22. K. D. Martyn, L. M. Frederick, K. von Loehneysen, M. C. Dinauer, U. G. Knaus, Cell. Signal. 18, 69 (2006). 23. F. E. Rey, M. E. Cifuentes, A. Kiarash, M. T. Quinn, P. J. Pagano, Circ. Res. 89, 408 (2001). 24. A. Best, S. Ahmed, R. Kozma, L. Lim, J. Biol. Chem. 271, 3756 (1996). 25. G. Sánchez et al., Cardiovasc. Res. 77, 380 (2008). 26. L. F. Santana, H. Cheng, A. M. Gómez, M. B. Cannell, W. J. Lederer, Circ. Res. 78, 166 (1996). 27. I. A. Williams, D. G. Allen, Am. J. Physiol. Heart Circ. Physiol. 292, H846 (2007). 28. S. Hein, S. Kostin, A. Heling, Y. Maeno, J. Schaper, Cardiovasc. Res. 45, 273 (2000). Acknowledgments: We thank S. Martin for antibodies to tubulin subunits and for discussion, G. Shi for technical assistance, and M. Williams for NOX2 animals. B.L.P is supported by an NIH training grant (T32 HL072751-07) to the Training Program in Cardiovascular Cell Biology. This work was supported by NIH grants R01 HL106059, P01 HL67849, R01 HL36974, RC2 NR011968, and S10 RR023028; Leducq North American-European Atrial Fibrillation Research Alliance; European Union Seventh Framework Program (FP7), Georg August University, “Identification and therapeutic targeting of common arrhythmia trigger mechanisms”; and the Maryland Stem Cell Research Fund. World Precision Instruments (WPI, Sarasota, FL, USA and SI-Heidelberg), Gabe Sinclair (Fourhourday, Baltimore, MD, USA), and Siskiyou (Grants Pass, OR, USA) supported instrumentation and equipment development.